相关实验视频
Updated: Jul 27, 2025

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema
Published on: January 12, 2017
多发性硬化症的临床过程和患者在乳腺癌治疗期间的经验
Alyssa N Nylander1, Jessica Singh1, Shane Poole1
1Weill Institute for Neurosciences, University of California San Francisco (UCSF), San Francisco, CA, USA.
多发性硬化症 (MS) 患有乳腺癌的患者经历了罕见的MS复发和稳定的残疾. 瘤结局与没有多发性硬化症的患者相似,表明可管理的并发性疾病轨迹.
科学领域:
- 在瘤学瘤学.
- 神经学 神经学
- 临床医学 临床医学
背景情况:
- 超过三分之一的多发性硬化症 (MS) 患者是绝经后的女性,这一人口群体也主要受到乳腺癌的影响.
- 关于被诊断患有多发性硬化症和乳腺癌的患者的临床经验,信息有限.
研究的目的:
- 在两种疾病患者的病例系列中描述瘤和MS轨迹.
- 为管理并发性多发性硬化和乳腺癌诊断的临床考虑产生新的见解.
主要方法:
- 一个单一中心对MS和乳腺癌患者的医疗记录进行了回顾性审查.
- 采用主题分析来描述患者与并发诊断的经验.
主要成果:
- 该研究包括43名患者,癌症诊断时平均年龄为56.7岁,MS持续时间为16.5年.
- 在随访期间,14%的患者经历了MS复发 (年均复发率为0.03),扩展残疾状况量表 (EDSS) 评分稳定.
- 在这个人群中,针对免疫抑制使用和神经系统症状的定性见解被确定.
结论:
- 多发性硬化症复发不常见,乳腺癌治疗期间残疾进展适度.
- 多发性硬化症患者的瘤结局与患有类似癌症阶段的非多发性硬化症患者相似.
更多相关视频
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
相关概念视频
Cancer Survival Analysis
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Disorders of the Female Reproductive System
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...